Carl-Johan Dalsgaard

Directeur Général chez INTERVACC AB

Profil

Dr. Carl-Johan Dalsgaard is a Group Chief Executive Officer at Intervacc AB, a Partner at HealthCap AB, a Chief Executive Officer at BioCrine AB, a Chief Executive Officer at BioFactor Therapeutics AB, a Chief Executive Officer at CePeP AB, a Member at Healthcap IV GP AB and a Member at Healthcap IV GP SA. Dr. Dalsgaard was previously employed as a Chief Executive Officer by Vicore Pharma Holding AB, an Independent Director by Tengion, Inc., a Chief Executive Officer by Biolipox AB, a Principal by Odlander, Fredrikson & Co. AB, a Vice President & Head-Therapy by Astra AB, a Chief Executive Officer by Astra Pain Control AB, a Director-Preclinical Research by AstraZeneca AB, a Chief Executive Officer & Director by INIM Pharma AB, a Managing Director by Karolinska Institutet Innovations AB, a Chief Executive Officer by LTB4 Sweden AB, a Chief Executive Officer by RSPR Pharma AB, and a Chief Executive Officer & Director by Vicore Pharma AB. He also served on the board at Affibody AB. He received his doctorate degree from Karolinska Institutet and a doctorate degree from Harvard Medical School.

Postes actifs de Carl-Johan Dalsgaard

Sociétés	Poste	Début
INTERVACC AB	Directeur Général	05/02/2026
Healthcap IV GP AB	Corporate Officer/Principal	-
Healthcap IV GP SA	Corporate Officer/Principal	-
HealthCap AB	Private Equity Investor	03/08/2010
BioCrine AB	Directeur Général	14/08/2009
CePeP AB	Directeur Général	14/08/2009
BioFactor Therapeutics AB	Directeur Général	14/08/2009

Anciens postes connus de Carl-Johan Dalsgaard

Sociétés	Poste	Fin
VICORE PHARMA HOLDING AB	Directeur Général	09/09/2023
Biolipox AB	President	-
░░░░ ░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-